Modeling tuberculosis in nonhuman primates.

Nonhuman primates have emerged as an excellent model of human tuberculosis, in large part because they recapitulate the full spectrum of infection outcome and pathology seen in humans. Several variables inherent to the nonhuman primate models of tuberculosis are discussed in this review, including the monkey species, Mycobacterium tuberculosis strains, and routes of infection, all of which can influence the model to be chosen for various studies. New technologies for studying the microbiology, immunology, and pathogenesis of tuberculosis in nonhuman primates have greatly expanded the capabilities of this model for basic and translational studies, including the development and testing of new treatment and prevention strategies for tuberculosis.

[1]  J. Keane.  Tumor necrosis factor blockers and reactivation of latent tuberculosis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  C. Kirkpatrick,et al.  The Relationship between Drug Clearance and Body Size , 2012, Clinical Pharmacokinetics.

[3]  Bruno Jedynak,et al.  Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-d-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment , 2009, Antimicrobial Agents and Chemotherapy.

[4]  J. Flynn,et al.  Pulmonary Tuberculosis in Monkeys , 2010 .

[5]  T. Taniyama,et al.  Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis. , 2009, Tuberculosis.

[6]  F. Gleeson,et al.  Early lesions following aerosol infection of rhesus macaques (Macaca mulatta) with Mycobacterium tuberculosis strain H37RV. , 2013, Journal of comparative pathology.

[7]  S. Primack,et al.  High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. , 2006, Microbes and infection.

[8]  I. Orme,et al.  Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model. , 2008, Tuberculosis.

[9]  A. Thomas,et al.  Divergent effect of bacillus Calmette–Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: Implications for primate models in tuberculosis vaccine research , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Flynn,et al.  Differential Virulence and Disease Progression following Mycobacterium tuberculosis Complex Infection of the Common Marmoset (Callithrix jacchus) , 2013, Infection and Immunity.

[11]  J. Flynn,et al.  CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques. , 2012, AIDS research and human retroviruses.

[12]  P. Andersen,et al.  The success and failure of BCG — implications for a novel tuberculosis vaccine , 2005, Nature Reviews Microbiology.

[13]  M. Cynamon,et al.  Activities of Several Novel Oxazolidinones againstMycobacterium tuberculosis in a Murine Model , 1999, Antimicrobial Agents and Chemotherapy.

[14]  M. Simon,et al.  Induction of an AIDS Virus-Related Tuberculosis-Like Disease in Macaques: a Model of Simian Immunodeficiency Virus- Mycobacterium Coinfection , 2002, Infection and Immunity.

[15]  JoAnne L. Flynn,et al.  Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. tuberculosis Infection , 2003, Infection and Immunity.

[16]  M. Chase,et al.  Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection , 2011, Nature Genetics.

[17]  E. Muñoz-Elías,et al.  Replication Dynamics of Mycobacterium tuberculosis in Chronically Infected Mice , 2005, Infection and Immunity.

[18]  D. Follmann,et al.  Linezolid for treatment of chronic extensively drug-resistant tuberculosis. , 2012, The New England journal of medicine.

[19]  R. Benson,et al.  A tuberculosis outbreak in a Macaca mulatta colony. , 1955, American review of tuberculosis.

[20]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[21]  A. Williams,et al.  Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models , 2011, Journal of applied microbiology.

[22]  L. H. Schmidt.  STUDIES ON THE ANTITUBERCULOUS ACTIVITY OF ETHAMBUTOL IN MONKEYS * , 1966, Annals of the New York Academy of Sciences.

[23]  J. Flynn,et al.  Monocyte-Derived IL-5 Reduces TNF Production by Mycobacterium tuberculosis–specific CD4 T Cells during SIV/M. tuberculosis Coinfection , 2013, The Journal of Immunology.

[24]  M. Simon,et al.  Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis. , 1999, Journal of immunology.

[25]  C. Schroeder.  Acquired Tuberculosis in the Primate in Laboratories and Zoölogical Collections. , 1938, American journal of public health and the nation's health.

[26]  Y. Kaneda,et al.  Novel prophylactic and therapeutic vaccine against tuberculosis. , 2009, Vaccine.

[27]  Markus Sköld,et al.  Tuberculosis and HIV Co-Infection , 2012, PLoS pathogens.

[28]  B. Gormus,et al.  Evidence for a rhesus monkey model of asymptomatic tuberculosis , 2004, Journal of medical primatology.

[29]  P. Haslett,et al.  Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. , 1999, Journal of immunology.

[30]  J. Flynn,et al.  Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. , 2000, AIDS research and human retroviruses.

[31]  J. Flynn,et al.  Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques , 2012, Proceedings of the National Academy of Sciences.

[32]  R. Good,et al.  Immune responses in rhesus monkeys after bacillus Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis. , 1973, The American review of respiratory disease.

[33]  Robert J Wilkinson,et al.  The immune response in tuberculosis. , 2013, Annual review of immunology.

[34]  W. Busey,et al.  Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. , 2015, The American review of respiratory disease.

[35]  J. Flynn,et al.  Simian Immunodeficiency Virus-Induced Changes in T Cell Cytokine Responses in Cynomolgus Macaques with Latent Mycobacterium tuberculosis Infection Are Associated with Timing of Reactivation , 2011, The Journal of Immunology.

[36]  Schmidt Lh.  Some observations on the utility of simian pulmonary tuberculosis in defining the therapeutic potentialities of isoniazid. , 1956 .

[37]  Timothy J. Sturgeon,et al.  Reactivation of Latent Tuberculosis in Cynomolgus Macaques Infected with SIV Is Associated with Early Peripheral T Cell Depletion and Not Virus Load , 2010, PloS one.

[38]  L. Gabbasova,et al.  Global tuberculosis report (2014) , 2014 .

[39]  A. Myers,et al.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. , 2010, Arthritis and rheumatism.

[40]  Yan Ye,et al.  M. tuberculosis H37Rv Infection of Chinese Rhesus Macaques , 2011, Journal of Neuroimmune Pharmacology.

[41]  Peter G. Smith,et al.  Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis. , 2012, American journal of respiratory and critical care medicine.

[42]  A. Thomas,et al.  MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques , 2009, PloS one.

[43]  S. Lawn,et al.  Epidemiology of HIV-associated tuberculosis , 2009, Current opinion in HIV and AIDS.

[44]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[45]  James A. Raleigh,et al.  Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates , 2008, Infection and Immunity.

[46]  G. Zeng,et al.  DR*W201/P65 Tetramer Visualization of Epitope-Specific CD4 T-Cell during M. tuberculosis Infection and Its Resting Memory Pool after BCG Vaccination , 2009, PloS one.

[47]  R. Coler,et al.  Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys , 2009, Proceedings of the National Academy of Sciences.

[48]  H. Jomaa,et al.  Phosphoantigen/IL2 Expansion and Differentiation of Vγ2Vδ2 T Cells Increase Resistance to Tuberculosis in Nonhuman Primates , 2013, PLoS pathogens.

[49]  Y. Kaneda,et al.  Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models , 2011, Human vaccines.

[50]  Adrian V. S. Hill,et al.  Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing , 2010, Clinical and Vaccine Immunology.

[51]  P. Cardona,et al.  Low Dose Aerosol Fitness at the Innate Phase of Murine Infection Better Predicts Virulence amongst Clinical Strains of Mycobacterium tuberculosis , 2012, PloS one.

[52]  William R. Jacobs,et al.  A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis , 2009, PLoS pathogens.

[53]  J. Blanchard,et al.  Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus , 2011, Journal of medical primatology.

[54]  J. Pavlin,et al.  Mycobacterium tuberculosis infection in a closed colony of rhesus macaques (Macaca mulatta). , 2011, Journal of the American Association for Laboratory Animal Science : JAALAS.

[55]  Melisa L. Budde,et al.  Specific CD8+ T Cell Responses Correlate with Control of Simian Immunodeficiency Virus Replication in Mauritian Cynomolgus Macaques , 2012, Journal of Virology.

[56]  R. Good.  SIMIAN TUBERCULOSIS: IMMUNOLOGIC ASPECTS * , 1968 .

[57]  Jinchun Pan,et al.  Mycobacterium Tuberculosis Infection in Rhesus Monkeys (Macaca mulatta) and Evaluation of ESAT-6 and CFP10 as Immunodiagnostic Antigens# , 2013, Experimental animals.

[58]  S. Jones,et al.  Diagnosis of tuberculosis , 2003, The Lancet.

[59]  G. Middlebrook.  Biology of the mycobacterioses , 1968 .

[60]  A. Michel,et al.  The rise and fall of tuberculosis in a free-ranging chacma baboon troop in the Kruger National Park. , 2000, The Onderstepoort journal of veterinary research.

[61]  G. Griffiths,et al.  An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. , 2001, Cytometry.

[62]  Austin L. Hughes,et al.  Unusually High Frequency MHC Class I Alleles in Mauritian Origin Cynomolgus Macaques , 2005, The Journal of Immunology.

[63]  A. Myers,et al.  Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques , 2006, Infection and Immunity.

[64]  Hannah P. Gideon,et al.  Latent tuberculosis: what the host “sees”? , 2011, Immunologic research.

[65]  D. Sherman,et al.  The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. , 2012, The Journal of clinical investigation.

[66]  D. Mitchison,et al.  Experimental models of tuberculosis: can we trust the mouse? , 2009, American journal of respiratory and critical care medicine.

[67]  P. Coleman,et al.  Infection in Rhesus (Macaca mulatta) and Squirrel (Saimiri sciureus) Monkeys due to Mycobacterium tuberculosis Phage Type B , 1981, Journal of medical primatology.

[68]  B. Gormus,et al.  Spectrum of manifestations of Mycobacterium tuberculosis infection in primates infected with SIV. , 2003, AIDS research and human retroviruses.

[69]  M. Simon,et al.  Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. , 2002, Science.

[70]  K. Mansfield,et al.  Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate. , 2011, Vaccine.

[71]  P. B. Fourie,et al.  Mycobacterium tuberculosis in a closed colony of baboons (Papio ursinus) , 1983, Laboratory animals.

[72]  S. Kaufmann,et al.  Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? , 2012, PLoS pathogens.

[73]  P. Luciw,et al.  Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[74]  J. Grosset,et al.  Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model , 2008, Antimicrobial Agents and Chemotherapy.

[75]  R. Good,et al.  Tuberculin-induced lymphocyte transformation and skin reactivity in monkeys vaccinated or not vaccinated with Bacille Calmette-Guérin, then challenged with virulent Mycobacterium tuberculosis. , 1975, The American review of respiratory disease.

[76]  F. Verreck,et al.  Prime-Boost Vaccination with rBCG/rAd35 Enhances CD8+ Cytolytic T-Cell Responses in Lesions from Mycobacterium Tuberculosis-Infected Primates , 2012, Molecular medicine.

[77]  Jian Wang,et al.  Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques , 2011, Nature Biotechnology.

[78]  Jennifer J. Lhost,et al.  Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells , 2009, Journal of Virology.

[79]  S. Mikota,et al.  Mycobacterium tuberculosis in zoo and wildlife species. , 2001, Revue scientifique et technique.

[80]  JoAnne L. Flynn,et al.  Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model , 2009, Infection and Immunity.

[81]  Simeone Marino,et al.  A multifaceted approach to modeling the immune response in tuberculosis , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[82]  W. Jacobs,et al.  A Recombinant Attenuated Mycobacterium tuberculosis Vaccine Strain Is Safe in Immunosuppressed Simian Immunodeficiency Virus-Infected Infant Macaques , 2012, Clinical and Vaccine Immunology.

[83]  F. Gleeson,et al.  Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis. , 2009, Tuberculosis.

[84]  Matthew Panarella,et al.  A naturally occurring outbreak of tuberculosis in a group of imported cynomolgus monkeys (Macaca fascicularis). , 2010, Journal of the American Association for Laboratory Animal Science : JAALAS.

[85]  M. Reed,et al.  Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. , 2005, The Journal of infectious diseases.

[86]  A. Michel,et al.  Mycobacterium tuberculosis at the human/wildlife interface in a high TB burden country. , 2013, Transboundary and emerging diseases.

[87]  M. Horwitz,et al.  The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease , 1996, Nature Medicine.

[88]  JoAnne L. Flynn,et al.  Understanding Latent Tuberculosis: A Moving Target , 2010, The Journal of Immunology.

[89]  JoAnne L. Flynn,et al.  Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing , 2014 .

[90]  W. Barclay,et al.  Aerosol-Induced Tuberculosis in Subhuman Primates and the Course of the Disease After Intravenous BCG Vaccination , 1970, Infection and immunity.

[91]  C. Laymon,et al.  Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [18F]2-Fluoro-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography , 2012, Antimicrobial Agents and Chemotherapy.

[92]  W. Barclay,et al.  Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey. , 1971, The Journal of infectious diseases.

[93]  M. Brennan,et al.  A rational vaccine pipeline for tuberculosis. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[94]  JoAnne L. Flynn,et al.  Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens , 2013, Antimicrobial Agents and Chemotherapy.